EIS funds - investments with a difference

77 High Street
Bagshot
Surrey
GU19 5AH

08456 499881

Send an Enquiry ›

4 December 12 - Sky Medical : ICI Innovation Awards Best Business Start-Up 2012


Sky Medical Ltd’s geko™ DVT device has won the ICI (“Innovations in Cardiovascular Interventions”) Innovation Awards Best Business Start-Up Award for 2012 at a ceremony attended by 1200 international cardiologists.

Geko™ is a non-invasive method for preventing Deep Vein Tthrombosis.  The one size fits all device uses patented technology to stimulate the nerve at the back of the knee and stimulate contraction of the calf, shin and foot muscles.  This improves blood circulation and oxygen levels almost equivalent of walking but when the patient is not mobile, for example after surgery or during a long haul airplane journey.

Sky Medical believe that the technology can replace the need for cumbersome foot pumps or other mechanical devices that are currently in use.  Unlike the existing devices Geko can allow the patient to get up from bed and mobilise early.

In the UK, there are more deaths per year from blood clots than from breast cancer, road traffic accidents and AIDS combined, and this inspired us to find a better solution than already existed .” said Bernard Ross, CEO of Sky Medical Technology Limited.

We are honoured to have won this prestigious Award, judged by some of the world’s foremost experts in the field.  This will help increase our visibility to the clinical world and speed up adoption of this important technology to improve patient care”.

Chairman of the Judging Panel, Professor Martin Rothman stated, “The Judges were enthused by the wealth of innovation and entrepreneurship displayed by the shortlisted candidates. The winner was selected because of its simplicity, clear potential to have clinical impact and business opportunity

About the ICI Innovation Awards

The “Innovations in Cardiovascular Interventions” (ICI) Innovation Awards is the world’s largest and prestigious award for cardiovascular start-ups.

The ICI Innovation Award offers cardiovascular Start-Up’s the opportunity to obtain critical peer review and feedback from a world class panel of clinical and commercial experts.  Entrants are invited to pitch their idea face to face to the Who’s Who panel of experts who then quiz them on the clinical and commercial opportunity.  The panel of Judges determine the winner based on three principal criteria: the impact on novelty; impact on patient care; and the business potential.

Winning an ICI Innovation Award offers unparalleled clinical and commercial validation.  The winner is offered assistance, guidance and contacts to drive the idea towards benefitting patients.  Winners also are offered the opportunity to present their innovation to thousands of doctors both at the ICI Meeting as well as at Europe’s largest cardiovascular meeting, EuroPCR in May 2013.  The ICI Innovation Awards are run in association with the “Innovations in Cardiovascular Interventions” (ICI) Meeting which takes place in December in Tel Aviv in Israel (see www.icimeeting.com)

The competition is in its second year, and each year more than 70 applications from 22 countries around the world enter and are whittled down to a shortlist of just 10 who are invited to present.  The Awards are supported by an unrestricted educational grant from Medtronic Inc.

Sky Medical manufacture medical devices using OnPulseTM, Sky Medical’s proprietary neuromuscular electro-stimulation technology.  The gekoTM device and OnPulseTM technology are registered trademarks of Sky Medical Technology Limited and are covered by granted and pending patents.  All intellectual property is held by Sky Medical Technology Ltd and covers the use of the OnPulseTM technology in a range of medical indications.  The gekoTM device, incorporating OnPulseTM technology, has received CE Marking and is approved in Europe, Australia and Canada for increasing blood circulation, for the prevention of venous thrombosis, for the prevention and treatment of oedema, for promoting wound healing and for the treatment of venous insufficiency and ischemia.  The gekoTM device and other embodiments of the OnPulseTM technology have not been cleared by the US FDA and are not available for sale in the USA.

To find out more about the gekoTM device and OnPulseTM technology please visit: http://www.gekodevices.com

Back to News | Next Story